ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:54 am Sale |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
ADAGE CAPITAL PARTNERS GP LLC | 899,997 1.470% |
-1,350,003 (-60.00%) |
Filing |
| 2021-02-11 07:29 am Sale |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
ADAGE CAPITAL PARTNERS GP LLC | 2,250,000 5.240% |
-250,000 (-10.00%) |
Filing |
| 2020-06-26 4:25 pm Purchase |
2020-06-17 | 13G | Aclaris Therapeutics, Inc. ACRS |
ADAGE CAPITAL PARTNERS GP LLC | 2,500,000 5.970% |
2,500,000 (New Position) |
Filing |